APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lexapro

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Lexapro Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025197 pages

Choose your research edition.

Industry ResearchLexapro Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Lexapro Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Lexapro Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lexapro Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Lexapro Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global Lexapro market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Lexapro is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lexapro is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lexapro is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Lexapro is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Lexapro include Zhejiang Conba Pharmaceutical (CN), Zhejiang Huahai Pharmaceutical (CN), Xidian Pharmaceutical (CN), Xian Janssen Pharmaceutical (CN), TEVA (Israel), Sichuan Kelun Pharmaceutical (CN), Jewim Pharmaceutical (Shandong), Novartis (US) and Mylan (US), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Lexapro market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lexapro and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lexapro sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lexapro market size, projected growth trends, production technologies, key applications, and end-use industries.

Lexapro Segment by Company

Zhejiang Conba Pharmaceutical (CN)

Zhejiang Huahai Pharmaceutical (CN)

Xidian Pharmaceutical (CN)

Xian Janssen Pharmaceutical (CN)

TEVA (Israel)

Sichuan Kelun Pharmaceutical (CN)

Jewim Pharmaceutical (Shandong)

Novartis (US)

Mylan (US)

Hunan Dongting Pharmaceutical (CN)

Lundbeck (DK)

Silarx Pharmacueticals (US)

Macleods Pharmaceuticals (IN)

Lupin (IN)

Hikma Pharmaceuticals (UK)

Hetero Drugs (IN)

Forest Laboratories (US)

Aurobindo Pharma (IN)

Apotex (CA)

Amneal Pharmaceuticals (US)

Accord Healthcare (IN)

Lexapro Segment by Type

Tablets

Solution

Lexapro Segment by Application

Children

Adults

Lexapro Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lexapro market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lexapro and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lexapro.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lexapro market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Lexapro manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Lexapro in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Lexapro in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Lexapro Industry Trends Table 2. Lexapro Industry Drivers Table 3. Lexapro Industry Opportunities and Challenges Table 4. Lexapro Industry Restraints Table 5. Global Lexapro Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Lexapro Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Lexapro Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Lexapro Sales Market Share by Manufacturers Table 9. Global Lexapro Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Lexapro Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Lexapro Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Lexapro Manufacturers, Product Type & Application Table 13. Global Lexapro Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Lexapro by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tablets Table 17. Major Manufacturers of Solution Table 18. Global Lexapro Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Lexapro Sales by Type (2021-2026) & (K Units) Table 20. Global Lexapro Sales by Type (2027-2032) & (K Units) Table 21. Global Lexapro Sales Market Share by Type (2021-2026) Table 22. Global Lexapro Sales Market Share by Type (2027-2032) Table 23. Global Lexapro Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Lexapro Revenue by Type (2021-2026) & (K Units) Table 25. Global Lexapro Revenue by Type (2027-2032) & (K Units) Table 26. Global Lexapro Revenue Market Share by Type (2021-2026) Table 27. Global Lexapro Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Children Table 29. Major Manufacturers of Adults Table 30. Global Lexapro Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Lexapro Sales by Application (2021-2026) & (K Units) Table 32. Global Lexapro Sales by Application (2027-2032) & (K Units) Table 33. Global Lexapro Sales Market Share by Application (2021-2026) Table 34. Global Lexapro Sales Market Share by Application (2027-2032) Table 35. Global Lexapro Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Lexapro Revenue by Application (2021-2026) & (K Units) Table 37. Global Lexapro Revenue by Application (2027-2032) & (K Units) Table 38. Global Lexapro Revenue Market Share by Application (2021-2026) Table 39. Global Lexapro Revenue Market Share by Application (2027-2032) Table 40. Global Lexapro Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Lexapro Sales by Region (2021-2026) & (K Units) Table 42. Global Lexapro Sales Market Share by Region (2021-2026) Table 43. Global Lexapro Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Lexapro Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Lexapro Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Lexapro Sales by Country (2021-2026) & (K Units) Table 47. North America Lexapro Sales by Country (2027-2032) & (K Units) Table 48. Europe Lexapro Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Lexapro Sales by Country (2021-2026) & (K Units) Table 50. Europe Lexapro Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Lexapro Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Lexapro Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Lexapro Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Lexapro Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Lexapro Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Lexapro Sales by Country (2027-2032) & (K Units) Table 57. Global Lexapro Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Lexapro Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Lexapro Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Lexapro Revenue Market Share by Region (2021-2026) Table 61. Global Lexapro Revenue Market Share by Region (2027-2032) Table 62. Zhejiang Conba Pharmaceutical (CN) Company Information Table 63. Zhejiang Conba Pharmaceutical (CN) Business Overview Table 64. Zhejiang Conba Pharmaceutical (CN) Lexapro Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Zhejiang Conba Pharmaceutical (CN) Lexapro Product Portfolio Table 66. Zhejiang Conba Pharmaceutical (CN) Recent Development Table 67. Zhejiang Huahai Pharmaceutical (CN) Company Information Table 68. Zhejiang Huahai Pharmaceutical (CN) Business Overview Table 69. Zhejiang Huahai Pharmaceutical (CN) Lexapro Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Zhejiang Huahai Pharmaceutical (CN) Lexapro Product Portfolio Table 71. Zhejiang Huahai Pharmaceutical (CN) Recent Development Table 72. Xidian Pharmaceutical (CN) Company Information Table 73. Xidian Pharmaceutical (CN) Business Overview Table 74. Xidian Pharmaceutical (CN) Lexapro Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Xidian Pharmaceutical (CN) Lexapro Product Portfolio Table 76. Xidian Pharmaceutical (CN) Recent Development Table 77. Xian Janssen Pharmaceutical (CN) Company Information Table 78. Xian Janssen Pharmaceutical (CN) Business Overview Table 79. Xian Janssen Pharmaceutical (CN) Lexapro Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Xian Janssen Pharmaceutical (CN) Lexapro Product Portfolio Table 81. Xian Janssen Pharmaceutical (CN) Recent Development Table 82. TEVA (Israel) Company Information Table 83. TEVA (Israel) Business Overview Table 84. TEVA (Israel) Lexapro Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. TEVA (Israel) Lexapro Product Portfolio Table 86. TEVA (Israel) Recent Development Table 87. Sichuan Kelun Pharmaceutical (CN) Company Information Table 88. Sichuan Kelun Pharmaceutical (CN) Business Overview Table 89. Sichuan Kelun Pharmaceutical (CN) Lexapro Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Sichuan Kelun Pharmaceutical (CN) Lexapro Product Portfolio Table 91. Sichuan Kelun Pharmaceutical (CN) Recent Development Table 92. Jewim Pharmaceutical (Shandong) Company Information Table 93. Jewim Pharmaceutical (Shandong) Business Overview Table 94. Jewim Pharmaceutical (Shandong) Lexapro Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Jewim Pharmaceutical (Shandong) Lexapro Product Portfolio Table 96. Jewim Pharmaceutical (Shandong) Recent Development Table 97. Novartis (US) Company Information Table 98. Novartis (US) Business Overview Table 99. Novartis (US) Lexapro Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Novartis (US) Lexapro Product Portfolio Table 101. Novartis (US) Recent Development Table 102. Mylan (US) Company Information Table 103. Mylan (US) Business Overview Table 104. Mylan (US) Lexapro Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Mylan (US) Lexapro Product Portfolio Table 106. Mylan (US) Recent Development Table 107. Hunan Dongting Pharmaceutical (CN) Company Information Table 108. Hunan Dongting Pharmaceutical (CN) Business Overview Table 109. Hunan Dongting Pharmaceutical (CN) Lexapro Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Hunan Dongting Pharmaceutical (CN) Lexapro Product Portfolio Table 111. Hunan Dongting Pharmaceutical (CN) Recent Development Table 112. Lundbeck (DK) Company Information Table 113. Lundbeck (DK) Business Overview Table 114. Lundbeck (DK) Lexapro Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Lundbeck (DK) Lexapro Product Portfolio Table 116. Lundbeck (DK) Recent Development Table 117. Silarx Pharmacueticals (US) Company Information Table 118. Silarx Pharmacueticals (US) Business Overview Table 119. Silarx Pharmacueticals (US) Lexapro Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Silarx Pharmacueticals (US) Lexapro Product Portfolio Table 121. Silarx Pharmacueticals (US) Recent Development Table 122. Macleods Pharmaceuticals (IN) Company Information Table 123. Macleods Pharmaceuticals (IN) Business Overview Table 124. Macleods Pharmaceuticals (IN) Lexapro Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Macleods Pharmaceuticals (IN) Lexapro Product Portfolio Table 126. Macleods Pharmaceuticals (IN) Recent Development Table 127. Lupin (IN) Company Information Table 128. Lupin (IN) Business Overview Table 129. Lupin (IN) Lexapro Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Lupin (IN) Lexapro Product Portfolio Table 131. Lupin (IN) Recent Development Table 132. Hikma Pharmaceuticals (UK) Company Information Table 133. Hikma Pharmaceuticals (UK) Business Overview Table 134. Hikma Pharmaceuticals (UK) Lexapro Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Hikma Pharmaceuticals (UK) Lexapro Product Portfolio Table 136. Hikma Pharmaceuticals (UK) Recent Development Table 137. Hetero Drugs (IN) Company Information Table 138. Hetero Drugs (IN) Business Overview Table 139. Hetero Drugs (IN) Lexapro Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Hetero Drugs (IN) Lexapro Product Portfolio Table 141. Hetero Drugs (IN) Recent Development Table 142. Forest Laboratories (US) Company Information Table 143. Forest Laboratories (US) Business Overview Table 144. Forest Laboratories (US) Lexapro Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. Forest Laboratories (US) Lexapro Product Portfolio Table 146. Forest Laboratories (US) Recent Development Table 147. Aurobindo Pharma (IN) Company Information Table 148. Aurobindo Pharma (IN) Business Overview Table 149. Aurobindo Pharma (IN) Lexapro Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 150. Aurobindo Pharma (IN) Lexapro Product Portfolio Table 151. Aurobindo Pharma (IN) Recent Development Table 152. Apotex (CA) Company Information Table 153. Apotex (CA) Business Overview Table 154. Apotex (CA) Lexapro Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 155. Apotex (CA) Lexapro Product Portfolio Table 156. Apotex (CA) Recent Development Table 157. Amneal Pharmaceuticals (US) Company Information Table 158. Amneal Pharmaceuticals (US) Business Overview Table 159. Amneal Pharmaceuticals (US) Lexapro Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 160. Amneal Pharmaceuticals (US) Lexapro Product Portfolio Table 161. Amneal Pharmaceuticals (US) Recent Development Table 162. Accord Healthcare (IN) Company Information Table 163. Accord Healthcare (IN) Business Overview Table 164. Accord Healthcare (IN) Lexapro Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 165. Accord Healthcare (IN) Lexapro Product Portfolio Table 166. Accord Healthcare (IN) Recent Development Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Lexapro Distributors List Table 170. Lexapro Customers List Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. Lexapro Product Image Figure 2. Global Lexapro Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lexapro Market Size (2021-2032) & (US$ Million) Figure 4. Global Lexapro Sales (2021-2032) & (K Units) Figure 5. Global Lexapro Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Lexapro Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tablets Image Figure 9. Solution Image Figure 10. Global Lexapro Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Lexapro Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Lexapro Sales Market Share by Type (2021-2032) Figure 13. Global Lexapro Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Lexapro Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Lexapro Revenue Market Share by Type (2021-2032) Figure 16. Children Image Figure 17. Adults Image Figure 18. Global Lexapro Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Lexapro Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Lexapro Sales Market Share by Application (2021-2032) Figure 21. Global Lexapro Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Lexapro Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Lexapro Revenue Market Share by Application (2021-2032) Figure 24. North America Lexapro Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Lexapro Sales Market Share by Country (2021-2032) Figure 26. U.S. Lexapro Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Lexapro Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Lexapro Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Lexapro Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Lexapro Sales Market Share by Country (2021-2032) Figure 31. Germany Lexapro Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Lexapro Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Lexapro Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Lexapro Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Lexapro Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Lexapro Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Lexapro Sales Market Share by Country (2021-2032) Figure 38. China Lexapro Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Lexapro Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Lexapro Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Lexapro Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Lexapro Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Lexapro Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Lexapro Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Lexapro Sales Market Share by Country (2021-2032) Figure 46. Brazil Lexapro Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Lexapro Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Lexapro Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Lexapro Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Lexapro Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Lexapro Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Lexapro Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Lexapro Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Lexapro Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Lexapro Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Lexapro Revenue (2021-2032) & (US$ Million) Figure 57. North America Lexapro Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Lexapro Revenue (2021-2032) & (US$ Million) Figure 59. Europe Lexapro Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Lexapro Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Lexapro Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Lexapro Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Lexapro Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Lexapro Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Lexapro Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Solution
Applications
  • Children
  • Adults
Companies covered
  • Zhejiang Conba Pharmaceutical (CN)
  • Zhejiang Huahai Pharmaceutical (CN)
  • Xidian Pharmaceutical (CN)
  • Xian Janssen Pharmaceutical (CN)
  • TEVA (Israel)
  • Sichuan Kelun Pharmaceutical (CN)
  • Jewim Pharmaceutical (Shandong)
  • Novartis (US)
  • Mylan (US)
  • Hunan Dongting Pharmaceutical (CN)
  • Lundbeck (DK)
  • Silarx Pharmacueticals (US)
  • Macleods Pharmaceuticals (IN)
  • Lupin (IN)
  • Hikma Pharmaceuticals (UK)
  • Hetero Drugs (IN)
  • Forest Laboratories (US)
  • Aurobindo Pharma (IN)
  • Apotex (CA)
  • Amneal Pharmaceuticals (US)
  • Accord Healthcare (IN)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Lexapro Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Lexapro Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Lexapro Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Lexapro Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Lexapro Market Dynamics
  1. 2.1 Lexapro Industry Trends
  2. 2.2 Lexapro Industry Drivers
  3. 2.3 Lexapro Industry Opportunities and Challenges
  4. 2.4 Lexapro Industry Restraints
3 Lexapro Market by Manufacturers
  1. 3.1 Global Lexapro Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Lexapro Sales by Manufacturers (2021-2026)
  3. 3.3 Global Lexapro Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Lexapro Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Lexapro Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Lexapro Manufacturers, Product Type & Application
  7. 3.7 Global Lexapro Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Lexapro Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Lexapro Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Lexapro Tier 1, Tier 2, and Tier 3
4 Lexapro Market by Type
  1. 4.1 Lexapro Type Introduction
  2. 4.1.1 Tablets
  3. 4.1.2 Solution
  4. 4.2 Global Lexapro Sales by Type
  5. 4.2.1 Global Lexapro Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Lexapro Sales by Type (2021-2032)
  7. 4.2.3 Global Lexapro Sales Market Share by Type (2021-2032)
  8. 4.3 Global Lexapro Revenue by Type
  9. 4.3.1 Global Lexapro Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Lexapro Revenue by Type (2021-2032)
  11. 4.3.3 Global Lexapro Revenue Market Share by Type (2021-2032)
5 Lexapro Market by Application
  1. 5.1 Lexapro Application Introduction
  2. 5.1.1 Children
  3. 5.1.2 Adults
  4. 5.2 Global Lexapro Sales by Application
  5. 5.2.1 Global Lexapro Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Lexapro Sales by Application (2021-2032)
  7. 5.2.3 Global Lexapro Sales Market Share by Application (2021-2032)
  8. 5.3 Global Lexapro Revenue by Application
  9. 5.3.1 Global Lexapro Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Lexapro Revenue by Application (2021-2032)
  11. 5.3.3 Global Lexapro Revenue Market Share by Application (2021-2032)
6 Global Lexapro Sales by Region
  1. 6.1 Global Lexapro Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lexapro Sales by Region (2021-2032)
  3. 6.2.1 Global Lexapro Sales by Region (2021-2026)
  4. 6.2.2 Global Lexapro Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Lexapro Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Lexapro Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Lexapro Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Lexapro Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Lexapro Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Lexapro Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Lexapro Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Lexapro Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Lexapro Revenue by Region
  1. 7.1 Global Lexapro Revenue by Region
  2. 7.1.1 Global Lexapro Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Lexapro Revenue by Region (2021-2026)
  4. 7.1.3 Global Lexapro Revenue by Region (2027-2032)
  5. 7.1.4 Global Lexapro Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Lexapro Revenue (2021-2032)
  8. 7.2.2 North America Lexapro Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Lexapro Revenue (2021-2032)
  11. 7.3.2 Europe Lexapro Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Lexapro Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Lexapro Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Lexapro Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Lexapro Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Conba Pharmaceutical (CN)
  2. 8.1.1 Zhejiang Conba Pharmaceutical (CN) Company Information
  3. 8.1.2 Zhejiang Conba Pharmaceutical (CN) Business Overview
  4. 8.1.3 Zhejiang Conba Pharmaceutical (CN) Lexapro Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Conba Pharmaceutical (CN) Lexapro Product Portfolio
  6. 8.1.5 Zhejiang Conba Pharmaceutical (CN) Recent Developments
  7. 8.2 Zhejiang Huahai Pharmaceutical (CN)
  8. 8.2.1 Zhejiang Huahai Pharmaceutical (CN) Company Information
  9. 8.2.2 Zhejiang Huahai Pharmaceutical (CN) Business Overview
  10. 8.2.3 Zhejiang Huahai Pharmaceutical (CN) Lexapro Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Zhejiang Huahai Pharmaceutical (CN) Lexapro Product Portfolio
  12. 8.2.5 Zhejiang Huahai Pharmaceutical (CN) Recent Developments
  13. 8.3 Xidian Pharmaceutical (CN)
  14. 8.3.1 Xidian Pharmaceutical (CN) Company Information
  15. 8.3.2 Xidian Pharmaceutical (CN) Business Overview
  16. 8.3.3 Xidian Pharmaceutical (CN) Lexapro Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Xidian Pharmaceutical (CN) Lexapro Product Portfolio
  18. 8.3.5 Xidian Pharmaceutical (CN) Recent Developments
  19. 8.4 Xian Janssen Pharmaceutical (CN)
  20. 8.4.1 Xian Janssen Pharmaceutical (CN) Company Information
  21. 8.4.2 Xian Janssen Pharmaceutical (CN) Business Overview
  22. 8.4.3 Xian Janssen Pharmaceutical (CN) Lexapro Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Xian Janssen Pharmaceutical (CN) Lexapro Product Portfolio
  24. 8.4.5 Xian Janssen Pharmaceutical (CN) Recent Developments
  25. 8.5 TEVA (Israel)
  26. 8.5.1 TEVA (Israel) Company Information
  27. 8.5.2 TEVA (Israel) Business Overview
  28. 8.5.3 TEVA (Israel) Lexapro Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 TEVA (Israel) Lexapro Product Portfolio
  30. 8.5.5 TEVA (Israel) Recent Developments
  31. 8.6 Sichuan Kelun Pharmaceutical (CN)
  32. 8.6.1 Sichuan Kelun Pharmaceutical (CN) Company Information
  33. 8.6.2 Sichuan Kelun Pharmaceutical (CN) Business Overview
  34. 8.6.3 Sichuan Kelun Pharmaceutical (CN) Lexapro Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sichuan Kelun Pharmaceutical (CN) Lexapro Product Portfolio
  36. 8.6.5 Sichuan Kelun Pharmaceutical (CN) Recent Developments
  37. 8.7 Jewim Pharmaceutical (Shandong)
  38. 8.7.1 Jewim Pharmaceutical (Shandong) Company Information
  39. 8.7.2 Jewim Pharmaceutical (Shandong) Business Overview
  40. 8.7.3 Jewim Pharmaceutical (Shandong) Lexapro Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Jewim Pharmaceutical (Shandong) Lexapro Product Portfolio
  42. 8.7.5 Jewim Pharmaceutical (Shandong) Recent Developments
  43. 8.8 Novartis (US)
  44. 8.8.1 Novartis (US) Company Information
  45. 8.8.2 Novartis (US) Business Overview
  46. 8.8.3 Novartis (US) Lexapro Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Novartis (US) Lexapro Product Portfolio
  48. 8.8.5 Novartis (US) Recent Developments
  49. 8.9 Mylan (US)
  50. 8.9.1 Mylan (US) Company Information
  51. 8.9.2 Mylan (US) Business Overview
  52. 8.9.3 Mylan (US) Lexapro Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Mylan (US) Lexapro Product Portfolio
  54. 8.9.5 Mylan (US) Recent Developments
  55. 8.10 Hunan Dongting Pharmaceutical (CN)
  56. 8.10.1 Hunan Dongting Pharmaceutical (CN) Company Information
  57. 8.10.2 Hunan Dongting Pharmaceutical (CN) Business Overview
  58. 8.10.3 Hunan Dongting Pharmaceutical (CN) Lexapro Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Hunan Dongting Pharmaceutical (CN) Lexapro Product Portfolio
  60. 8.10.5 Hunan Dongting Pharmaceutical (CN) Recent Developments
  61. 8.11 Lundbeck (DK)
  62. 8.11.1 Lundbeck (DK) Company Information
  63. 8.11.2 Lundbeck (DK) Business Overview
  64. 8.11.3 Lundbeck (DK) Lexapro Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Lundbeck (DK) Lexapro Product Portfolio
  66. 8.11.5 Lundbeck (DK) Recent Developments
  67. 8.12 Silarx Pharmacueticals (US)
  68. 8.12.1 Silarx Pharmacueticals (US) Company Information
  69. 8.12.2 Silarx Pharmacueticals (US) Business Overview
  70. 8.12.3 Silarx Pharmacueticals (US) Lexapro Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Silarx Pharmacueticals (US) Lexapro Product Portfolio
  72. 8.12.5 Silarx Pharmacueticals (US) Recent Developments
  73. 8.13 Macleods Pharmaceuticals (IN)
  74. 8.13.1 Macleods Pharmaceuticals (IN) Company Information
  75. 8.13.2 Macleods Pharmaceuticals (IN) Business Overview
  76. 8.13.3 Macleods Pharmaceuticals (IN) Lexapro Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Macleods Pharmaceuticals (IN) Lexapro Product Portfolio
  78. 8.13.5 Macleods Pharmaceuticals (IN) Recent Developments
  79. 8.14 Lupin (IN)
  80. 8.14.1 Lupin (IN) Company Information
  81. 8.14.2 Lupin (IN) Business Overview
  82. 8.14.3 Lupin (IN) Lexapro Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Lupin (IN) Lexapro Product Portfolio
  84. 8.14.5 Lupin (IN) Recent Developments
  85. 8.15 Hikma Pharmaceuticals (UK)
  86. 8.15.1 Hikma Pharmaceuticals (UK) Company Information
  87. 8.15.2 Hikma Pharmaceuticals (UK) Business Overview
  88. 8.15.3 Hikma Pharmaceuticals (UK) Lexapro Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Hikma Pharmaceuticals (UK) Lexapro Product Portfolio
  90. 8.15.5 Hikma Pharmaceuticals (UK) Recent Developments
  91. 8.16 Hetero Drugs (IN)
  92. 8.16.1 Hetero Drugs (IN) Company Information
  93. 8.16.2 Hetero Drugs (IN) Business Overview
  94. 8.16.3 Hetero Drugs (IN) Lexapro Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Hetero Drugs (IN) Lexapro Product Portfolio
  96. 8.16.5 Hetero Drugs (IN) Recent Developments
  97. 8.17 Forest Laboratories (US)
  98. 8.17.1 Forest Laboratories (US) Company Information
  99. 8.17.2 Forest Laboratories (US) Business Overview
  100. 8.17.3 Forest Laboratories (US) Lexapro Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Forest Laboratories (US) Lexapro Product Portfolio
  102. 8.17.5 Forest Laboratories (US) Recent Developments
  103. 8.18 Aurobindo Pharma (IN)
  104. 8.18.1 Aurobindo Pharma (IN) Company Information
  105. 8.18.2 Aurobindo Pharma (IN) Business Overview
  106. 8.18.3 Aurobindo Pharma (IN) Lexapro Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Aurobindo Pharma (IN) Lexapro Product Portfolio
  108. 8.18.5 Aurobindo Pharma (IN) Recent Developments
  109. 8.19 Apotex (CA)
  110. 8.19.1 Apotex (CA) Company Information
  111. 8.19.2 Apotex (CA) Business Overview
  112. 8.19.3 Apotex (CA) Lexapro Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Apotex (CA) Lexapro Product Portfolio
  114. 8.19.5 Apotex (CA) Recent Developments
  115. 8.20 Amneal Pharmaceuticals (US)
  116. 8.20.1 Amneal Pharmaceuticals (US) Company Information
  117. 8.20.2 Amneal Pharmaceuticals (US) Business Overview
  118. 8.20.3 Amneal Pharmaceuticals (US) Lexapro Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Amneal Pharmaceuticals (US) Lexapro Product Portfolio
  120. 8.20.5 Amneal Pharmaceuticals (US) Recent Developments
  121. 8.21 Accord Healthcare (IN)
  122. 8.21.1 Accord Healthcare (IN) Company Information
  123. 8.21.2 Accord Healthcare (IN) Business Overview
  124. 8.21.3 Accord Healthcare (IN) Lexapro Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Accord Healthcare (IN) Lexapro Product Portfolio
  126. 8.21.5 Accord Healthcare (IN) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Lexapro Value Chain Analysis
  2. 9.1.1 Lexapro Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Lexapro Production Mode & Process
  6. 9.2 Lexapro Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Lexapro Distributors
  9. 9.2.3 Lexapro Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst